[SCHEDULE 13G] Alto Neuroscience, Inc. SEC Filing
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman disclosed a 7.3% beneficial ownership stake in Alto Neuroscience, Inc. (ticker ANRO), representing 1,989,393 shares of common stock. The filing states the ownership percentage is calculated from 27,076,629 outstanding shares as of
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman hanno comunicato una partecipazione 7,3% di beneficiante in Alto Neuroscience, Inc. (ticker ANRO), che rappresenta 1,989,393 azioni ordinarie. La dichiarazione indica che la percentuale di proprietà è calcolata su 27,076,629 azioni in circolazione al
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman divulgan una participación del 7,3% en Alto Neuroscience, Inc. (ticker ANRO), que representa 1,989,393 acciones comunes. El escrito indica que el porcentaje de propiedad se calcula a partir de 27,076,629 acciones en circulación a partir del
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 및 Joseph Edelman은 Alto Neuroscience, Inc.의 7.3%의 유익한 소유 지분을 공개했습니다 (티커 ANRO), 이는 1,989,393주의 보통주를 나타냅니다. 공시에 의하면 소유 비율은 27,076,629 주의 발행 주식 중 남아 있는 주식 수를 기준으로
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman ont divulgué une participation bénéficiaire de 7,3% dans Alto Neuroscience, Inc. (ticker ANRO), représentant 1 989 393 actions ordinaires. Le dépôt indique que le pourcentage de propriété est calculé sur 27 076 629 actions en circulation au
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman haben eine 7,3%-Beteiligung an Alto Neuroscience, Inc. offengelegt (Wertpapierkennnummer ANRO), was 1.989.393 Stammaktien entspricht. Die Einreichung besagt, dass der Eigentumsanteil auf 27.076.629 ausstehende Aktien zum
أعلنت Perceptive Advisors LLC و Perceptive Life Sciences Master Fund, Ltd. وجوزيف إدلمان عن ملكية فعّالة بنسبة 7.3% في Alto Neuroscience, Inc. (رمز التداول ANRO)، تمثل 1,989,393 سهماً من الأسهم العادية. وتذكر العريضة أن نسبة الملكية محسوبة من 27,076,629 سهماً مطروحة في التداول حتى تاريخ
Perceptive Advisors LLC、Perceptive Life Sciences Master Fund, Ltd. 与 Joseph Edelman 披露在 Alto Neuroscience, Inc. 的 7.3% 实益所有权股份,代表 1,989,393 股普通股。 filing 表明所有权百分比是基于 27,076,629 股在外流通股份于
- Material disclosure: Reporting of a 7.3% stake ensures regulatory transparency for investors
- Single-block ownership: All reporting persons disclose the same 1,989,393 shares, reducing ambiguity about overlapping claims
- No sole voting or dispositive power reported, indicating limited unilateral influence over corporate decisions
- 7.3% stake may still exert market influence without a control intent, creating potential activist interest or trading volatility
Insights
Perceptive reports a material >5% passive stake and shared control of 1.99M shares.
The reported 1,989,393 shares equal
This position is described as shared voting and dispositive power and certified as not acquired to change control, indicating a likely passive or investment-management holding. Investors should note the holding is large enough to be a visible institutional stake but the filers disclaim a control intent in the near term.
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman hanno comunicato una partecipazione 7,3% di beneficiante in Alto Neuroscience, Inc. (ticker ANRO), che rappresenta 1,989,393 azioni ordinarie. La dichiarazione indica che la percentuale di proprietà è calcolata su 27,076,629 azioni in circolazione al
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman divulgan una participación del 7,3% en Alto Neuroscience, Inc. (ticker ANRO), que representa 1,989,393 acciones comunes. El escrito indica que el porcentaje de propiedad se calcula a partir de 27,076,629 acciones en circulación a partir del
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 및 Joseph Edelman은 Alto Neuroscience, Inc.의 7.3%의 유익한 소유 지분을 공개했습니다 (티커 ANRO), 이는 1,989,393주의 보통주를 나타냅니다. 공시에 의하면 소유 비율은 27,076,629 주의 발행 주식 중 남아 있는 주식 수를 기준으로
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman ont divulgué une participation bénéficiaire de 7,3% dans Alto Neuroscience, Inc. (ticker ANRO), représentant 1 989 393 actions ordinaires. Le dépôt indique que le pourcentage de propriété est calculé sur 27 076 629 actions en circulation au
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman haben eine 7,3%-Beteiligung an Alto Neuroscience, Inc. offengelegt (Wertpapierkennnummer ANRO), was 1.989.393 Stammaktien entspricht. Die Einreichung besagt, dass der Eigentumsanteil auf 27.076.629 ausstehende Aktien zum